1. Abrishami, M., Heravian, J., Derakhshan, A., Mousavi, M., Banaee, T., Daneshvar, R., et al. (2007). Abnormal Cambridge low-contrast grating sensitivity results associated with diabetic retinopathy as a potential screening tool. Eastern Mediterranean Health Journal, 13(4), 810–818.
2. Cugati, S., Cikamatana, L., Wang, J. J., Kifley, A., Liew, G., & Mitchell, P. (2006). Five-year incidence and progression of vascular retinopathy in persons without diabetes: The blue mountains eye study. Eye, 20, 1239–1245.
3. El-Remessy, A. B., Al-Shabrawey, M., Khalifa, Y., Tsai, N. T., Caldwell, R. B., & Liou, G. I. (2006). Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. American Journal of Pathology, 168, 235–244.
4. Harney, F. (2006). Diabetic retinopathy. Medicine, 34(3), 95–98.
5. Kanski, J. J. (1994). Diabetic retinopathy. In Clinical ophthalmology (pp. 344–357). London: Butterworth.